Derfor forventes det ikke, at fondaparinux vil interagere med andre lægemidler in vivo gennem hæmning af CYP- medieret metabolisme. er
Thus, fondaparinux is not expected to interact with other medicinal products in vivo by inhibition of CYP-mediated metabolism. ed